ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.331,39
-0,25%
S&P 500
5.469,30
0,39%
US Dollar vs BRL
5,4522
0,00%
Bitcoin
61.788,35
-0,02%
Brent Oil
84,665
0,57%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Allurion Technologies Inc (ALUR)

  7. Allurion Technologies Inc (ALUR) Notícias

ALUR

Allurion Technologies (ALUR)

Allurion Technologies Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:ALUR
DataHoraFonteTítuloCódigoCompanhia
20/06/202409:00Business WireAllurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight LossNYSE:ALURAllurion Technologies Inc
11/06/202409:00Business WireAllurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric SurgeryNYSE:ALURAllurion Technologies Inc
05/06/202419:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ALURAllurion Technologies Inc
05/06/202409:00Business WireAllurion Announces the Appointment of Ojas A. Buch as Chief Operating OfficerNYSE:ALURAllurion Technologies Inc
30/05/202409:00Business WireAllurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1sNYSE:ALURAllurion Technologies Inc
29/05/202417:05Business WireAllurion to Participate in Two Upcoming Investor Conferences in June 2024NYSE:ALURAllurion Technologies Inc
15/05/202409:00Business WireAllurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight LossNYSE:ALURAllurion Technologies Inc
14/05/202417:39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ALURAllurion Technologies Inc
14/05/202409:05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ALURAllurion Technologies Inc
14/05/202409:00Business WireAllurion Reports First Quarter 2024 Financial Results and Provides Business UpdateNYSE:ALURAllurion Technologies Inc
02/05/202409:00Business WireAllurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance SurveyNYSE:ALURAllurion Technologies Inc
30/04/202409:30Business WireAllurion Announces Preliminary First Quarter 2024 ResultsNYSE:ALURAllurion Technologies Inc
17/04/202409:31Business WireAllurion Closes $48 Million Convertible Senior Secured Note Financing with RTW InvestmentsNYSE:ALURAllurion Technologies Inc
04/04/202409:00Business WireAllurion Expands Virtual Care Suite to the United StatesNYSE:ALURAllurion Technologies Inc
21/03/202409:00Business WireAllurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 GuidanceNYSE:ALURAllurion Technologies Inc
13/03/202409:30Business WireAllurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceNYSE:ALURAllurion Technologies Inc
12/03/202409:00Business WireMilena Alberti-Perez Joins Allurion Board of Directors as Audit Committee ChairNYSE:ALURAllurion Technologies Inc
04/03/202410:30Business WireAllurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024NYSE:ALURAllurion Technologies Inc
20/02/202418:05Business WireAllurion to Participate in Cowen’s 44th Annual Health Care ConferenceNYSE:ALURAllurion Technologies Inc
08/02/202410:30Business WireAllurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceNYSE:ALURAllurion Technologies Inc
29/01/202410:00Business WireBrendan Gibbons Appointed Chief Legal Officer at Allurion TechnologiesNYSE:ALURAllurion Technologies Inc
23/01/202411:04Business WireSomerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight LossNYSE:ALURAllurion Technologies Inc
23/01/202410:15Business WireWorld first : Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight LossNYSE:ALURAllurion Technologies Inc
17/01/202410:00Business WireAllurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic PartnershipsNYSE:ALURAllurion Technologies Inc
11/01/202410:00Business WireAllurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-MorbiditiesNYSE:ALURAllurion Technologies Inc
08/01/202410:00Business WireAllurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 OutlookNYSE:ALURAllurion Technologies Inc
05/01/202410:00Business WireNew research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion ProgramNYSE:ALURAllurion Technologies Inc
02/01/202410:00Business WireAllurion’s Digital Platform Gains Traction with Expanded Strategic PartnershipNYSE:ALURAllurion Technologies Inc
13/11/202310:00Business WireAllurion Reports Third Quarter 2023 Financial Results and Provides Business UpdateNYSE:ALURAllurion Technologies Inc
06/11/202318:05Business WireAllurion to Participate in the Jefferies London Healthcare ConferenceNYSE:ALURAllurion Technologies Inc
 Apresentando as notícias mais relevantes sobre:NYSE:ALUR

Seu Histórico Recente

LSE
22LJ
Newday Pf 28 A
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados